Omada Health (NASDAQ:OMDA) Price Target Raised to $27.00

Omada Health (NASDAQ:OMDA) had its target price boosted by Citizens Jmp from $21.00 to $27.00 in a research report report published on Monday morning,Benzinga reports. They currently have a market outperform rating on the stock.

OMDA has been the topic of a number of other reports. Evercore reaffirmed an “outperform” rating and set a $20.00 target price on shares of Omada Health in a research report on Friday, May 8th. Citigroup reiterated an “outperform” rating on shares of Omada Health in a report on Monday. Wall Street Zen downgraded Omada Health from a “buy” rating to a “hold” rating in a report on Saturday, July 18th. Barclays lifted their target price on Omada Health from $18.00 to $20.00 and gave the company an “overweight” rating in a research report on Friday, May 8th. Finally, The Goldman Sachs Group reiterated a “buy” rating on shares of Omada Health in a report on Friday, May 8th. Eleven investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Omada Health presently has an average rating of “Moderate Buy” and an average target price of $24.33.

Omada Health Trading Down 5.0%

Shares of NASDAQ:OMDA opened at $21.84 on Monday. Omada Health has a 12 month low of $10.28 and a 12 month high of $26.92. The firm’s 50-day moving average is $19.47 and its 200 day moving average is $15.81. The company has a market capitalization of $1.30 billion and a price-to-earnings ratio of -80.89.

Omada Health (NASDAQ:OMDA) last announced its quarterly earnings data on Thursday, May 7th. The company reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.08) by $0.03. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%.The company had revenue of $78.05 million for the quarter. As a group, equities analysts forecast that Omada Health will post -0.01 EPS for the current fiscal year.

Insider Transactions at Omada Health

In other news, CAO Craig Gracey sold 2,083 shares of the company’s stock in a transaction that occurred on Monday, June 29th. The shares were sold at an average price of $21.00, for a total value of $43,743.00. Following the completion of the sale, the chief accounting officer owned 858 shares of the company’s stock, valued at approximately $18,018. This represents a 70.83% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Steven L. Cook sold 12,337 shares of Omada Health stock in a transaction that occurred on Tuesday, July 7th. The shares were sold at an average price of $23.09, for a total transaction of $284,861.33. Following the transaction, the chief financial officer directly owned 187,209 shares in the company, valued at approximately $4,322,655.81. The trade was a 6.18% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 193,462 shares of company stock valued at $3,927,425. Company insiders own 6.38% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Quarry LP purchased a new stake in shares of Omada Health during the 4th quarter worth $29,000. TD Waterhouse Canada Inc. purchased a new position in Omada Health in the fourth quarter valued at about $32,000. Raymond James Financial Inc. purchased a new stake in shares of Omada Health during the second quarter valued at about $32,000. Inlight Wealth Management LLC bought a new stake in shares of Omada Health in the 4th quarter valued at about $45,000. Finally, Versant Capital Management Inc boosted its holdings in shares of Omada Health by 319.3% in the 2nd quarter. Versant Capital Management Inc now owns 2,998 shares of the company’s stock valued at $66,000 after buying an additional 2,283 shares in the last quarter.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.